|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Vestal Point Capital LP
✚
|
|
|---|---|
| CRD # | 325894 |
| SEC # | 801-127682 |
| CIK # | 0001974915 |
| AUM | $2.8 B (2025-03-21) |
| Employees | 10 (70% Investors, 0% Brokers) |
| Phone | 646-989-4000 |
| Address | 632 Broadway New York, NY 10012 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| CIK | Period |
|---|---|
| 0001974915 |
| Sector | Form 13F Holdings | Value ($M) |
|---|---|---|
| Arcellx Inc | 181.1 | |
| Jazz Pharmaceuticals Inc | 127.3 | |
| Cytokinetics Inc | 98.3 | |
| Nuvalent Inc | 82.0 | |
| Vera Therapeutics Inc | 73.0 | |
| Amicus Therapeutics Inc | 68.2 | |
| Xenon Pharmaceuticals Inc | 62.6 | |
| Magenta Therapeutics Inc | 59.6 | |
| Scholar Rock Holding Corp | 53.1 | |
| Carbylan Therapeutics Inc | 52.9 | |
| GE Healthcare Technologies Inc | 51.8 | |
| Uniqure NV | 51.6 | |
| Bicara Therapeutics Inc | 46.5 | |
| Alcon Inc | 46.3 | |
| Revolution Medicines Inc | 44.1 | |
| Crinetics Pharmaceuticals Inc | 43.1 | |
| Exact Sciences Corp | 37.2 | |
| Celldex Therapeutics Inc | 35.6 | |
| Ascendis Pharma A/S | 34.5 | |
| Immatics NV | 33.6 | |
| Geron Corp | 33.5 | |
| Globus Medical Inc | 29.5 | |
| BioMarin Pharmaceutical Inc | 27.5 | |
| Helix Acquisition Corp | 26.0 | |
| TYRA Biosciences Inc | 25.4 | |
| Adventrx Pharmaceuticals Inc | 25.1 | |
| Cooper Companies Inc | 24.9 | |
| Structure Therapeutics Inc | 24.9 | |
| Cidara Therapeutics Inc | 24.4 | |
| Catabasis Pharmaceuticals Inc | 24.2 | Prev | Page 1 | Next |
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Vestal Point Master Fund LP | 2023-03-17 | 1,309.0 |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 1.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 1.5 |
| Total | 4 | 2.8 |
| By Discretionary | ||
| Discretionary | 4 | 2.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 2.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 2.2 | |
| United States Persons | 0.6 | |
| Total | 4 | 2.8 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001974915] | |
| SC 13G | [0001974915] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Anson Funds Management LP
✚
|
TX | 2.9 |
|
Impactive Capital LP
✚
|
NY | 2.8 |
|
Dwight Securities Management LLC
✚
|
FL | 2.8 |
|
Aventail Capital Group LP
✚
|
NY | 2.8 |
|
140 Summer Partners LP
✚
|
NY | 2.8 |
|
Phase 3 Capital Management LLC
✚
|
FL | 2.8 |
|
Fiera Capital UK Limited
✚
|
2.8 | |
|
Serone Capital Management LLP
✚
|
2.8 | |
|
EPFC Capital Partners LLC
✚
|
NY | 2.8 |
|
Strategic Income Management LLC
✚
|
WA | 2.7 |